NCT04448795

Brief Summary

This study investigated the impact of highest drain fluid amylase (DFA) level on postoperative pancreatic fistula (POPF) severity and outcomes of patients undergoing pancreaticoduodenectomy (PD) with POPF. Patient demographics of biochemical POPF and clinically relevant POPF (CR-POPF) were compared. Predictive factors were assessed using binary logistic regression. Receiver operating characteristic curve analysis was performed to determine the optimal cutoff value of highest DFA (beyond 3 days post-PD). The investigators compared length of hospital stay, surgical mortality rates, and need for postoperative interventions by highest DFA level.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2010

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2018

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2020

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

June 22, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 26, 2020

Completed
Last Updated

June 26, 2020

Status Verified

June 1, 2020

Enrollment Period

8 years

First QC Date

June 22, 2020

Last Update Submit

June 24, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • postoperative pancreatic fistula

    fluid output of any measureable volume via an operatively placed drain with amylase activity greater than 3 times the upper normal serum value

    through study completion, an average of 2 month

Secondary Outcomes (3)

  • postoperative interventions

    through study completion, an average of 2 month

  • length of hospital stay

    through study completion, an average of 2 month

  • 30-day mortality rates

    30 day

Eligibility Criteria

Age20 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

underwent PD in Chang Gung Memorial Hospital at Linkou

You may qualify if:

  • underwent PD from October 2010 to September 2018 in our institution

You may not qualify if:

  • younger than 20 years of age
  • clinical information was unavailable due to private or legal issues
  • receiving PD without pancreaticojejunostomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pancreatic Fistula

Condition Hierarchy (Ancestors)

Digestive System FistulaDigestive System DiseasesPancreatic DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2020

First Posted

June 26, 2020

Study Start

October 1, 2010

Primary Completion

September 30, 2018

Study Completion

May 30, 2020

Last Updated

June 26, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share